A New Gene Therapy Could Hold the Key to Curing Allergies and Asthma – Futurism
Futurism |
A New Gene Therapy Could Hold the Key to Curing Allergies and Asthma
Futurism Scientists from the University of Queensland have used gene therapy to turn off the immune response responsible for asthma. The team believes their technique may also be able to permanently silence severe allergy responses to common allergens such as … Gene therapy could wipe immune memory and “turn off” severe …New Atlas New gene therapy may ‘turn off’ asthmaThe Indian Express A New Gene Therapy that Can “Turn Off” Asthma and Food AllergiesNDTV Food Christian Post –Pune Mirror all 38 news articles » |
USC News |
Stem cells may be the key to staying strong in old age — ScienceDaily
Science Daily A new study, performed in mice, could lead to new approaches to help people stay stronger in old age. The study challenges conventional wisdom with results … Stem cell researcher takes on the brain’s fight against age-related diseasesUSC News |
|
Stem cell researcher takes on the brain’s fight against age-related diseases
USC News What happens to the stem cells in our brains as we age? Albina Ibrayeva, a PhD student in the USC Stem Cell laboratory of Michael Bonaguidi, addresses this question as she tries to understand how the brain naturally fights against aging and suggests … |
USC News |
Stem cell researcher takes on the brain’s fight against age-related diseases
USC News Albina Ibrayeva, a PhD student in the USC Stem Cell laboratory of Michael Bonaguidi, addresses this question as she tries to understand how the brain naturally fights against aging and suggests promising therapeutic avenues for treating age-related … |
|
Intellia, San Raffaele Partner on CRISPR/Cas9-Edited Anticancer T-Cell Therapies
Genetic Engineering & Biotechnology News The 3-year research collaboration, option, and license agreement will aim to leverage Intellia’s CRISPR/Cas9 genome-editing platform to generate improved T-cell therapies for both hematologic and solid tumors. The agreement includes options and … Intellia Therapeutics and San Raffaele University and Research Hospital to Combine CRISPR/Cas9 Genome Editing …GlobeNewswire (press release) Latest Stocks: Zacks: Crispr Therapeutics AG (CRSP) Receives Consensus Rating of “Strong Buy” from AnalystsPetro Global News 24 BRIEF-Intellia Therapeutics and San Raffaele University and Research Hospital to combine CRISPR/cas9 genome …Reuters MoneyMakingArticles all 6 news articles » |